Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Germany(1,705/week)
    • Poland(1,225/week)
    • France(1,077/week)
    • Spain(744/week)
    • Italy(447/week)
    • View all (7,856/week)
  • News
    • United States(643/week)
    • Manufacturing(475/week)
    • Energy(364/week)
    • Technology(472/week)
    • Other Manufacturing(409/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Favipiravir

Aug 13, 2020
ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection
Jun 22, 2020
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir
Jun 20, 2020
Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 01, 2020
RDIF and ChemRar to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia, Avifavir, to the Country's Hospitals in June
May 26, 2020
Glenmark to Commence New Phase 3 Clinical Trial on Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India
May 22, 2020
RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial
May 13, 2020
RDIF and ChemRar Announce First Interim Results of Clinical Trials of Favipiravir Drug's Effectiveness in Coronavirus Therapy
May 12, 2020
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir for COVID-19 Patients in India
Apr 23, 2020
CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients
Apr 15, 2020
Fujifilm accelerates production of its influenza antiviral drug "Avigan® Tablet" for COVID-19
Apr 08, 2020
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for Treatment of COVID-19
Mar 19, 2020
Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients

Latest News

Aug 10, 2022

Impact Podcast with John Shegerian Features Chastity McLeod from Nestlé USA

Aug 10, 2022

American Pacific Group Completes Investment in Concisys

Aug 10, 2022

Pennsylvania American Water Helps Plant Nearly 2,000 Trees in Recognition of Customers’ Switch to Paperless...

Aug 10, 2022

J29 Receives CMS Prime Contract Award

Aug 10, 2022

Terran Orbital to Present at Jefferies Industrials Conference

Aug 10, 2022

Kwik Lok to Feature Sustainable Closure Solutions at International Baking Industry Exposition 2022

Aug 10, 2022

Skyfish to Present at the Canaccord Genuity 42nd Annual Growth Conference

Aug 10, 2022

Nonprofit Funding Platform Heroe5 Launches The Good Society, Embracing Web3 Approach to the Sustainable...

View all News

Agenda

17
November
The NetherlandsAhoy, Rotterdam
NIDV Exhibition Defence and Security, November 17, 2022, Ahoy Rotterdam
The NIDV Exhibition Defence and Security (NEDS) is the annual event for the Defence and Security industry and...
02
November
GreeceAthens
mastMED 2022 - Maritime/Air Systems & Technologies, 2-4 November, Athens, Greece
“The Mediterranean: Laboratory for Naval Warfare” Between 2–4 November 2022, Athens will be the first Greek city to...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
© 2022 EPICOS
Made by Wedia